|
|
Home > Healthcare > Biotechnology > General Biotech
Omrix Biopharmaceuticals, Inc. Product Pipeline Analysis
|
|
Omrix Biopharmaceuticals, Inc. Product Pipeline Analysis
Summary
This report is an insightful source for data, analysis and strategic insights into a Omrix Biopharmaceuticals, Inc.’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
|
Similar Products
• Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications, 2nd Edition
Published Dec 2008 by Kalorama Information
• Biotechnology Report
Published Nov 2008 by Wall Street Transcript
• MarketWatch: Biotechnology
Published Nov 2008 by Datamonitor
• Amgen Inc. - SWOT Analysis - SWOT Analysis
Published Nov 2008 by Datamonitor
• 13th Annual International Detection Technologies 2008 Conference Documentation
Published Nov 2008 by Knowledge Foundation
• Biodetection Technologies 5th Edition
Published Nov 2008 by Knowledge Foundation
• The Royalty Rate Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
Published Nov 2008 by PharmaVentures Ltd.
• Freedonia Focus on Biochip Products & Services
Published Nov 2008 by Freedonia Focus
• Effective Competitive Intelligence: A "How-To" Guide for Life Science Companies
Published Nov 2008 by Kalorama Information
• Biotechnology in the US - Industry Risk Rating Report
Published Oct 2008 by IBISWorld
|
|
|
|
0 items
